Structure Therapeutics
GPCR
GPCR
48 hedge funds and large institutions have $699M invested in Structure Therapeutics in 2023 Q2 according to their latest regulatory filings, with 14 funds opening new positions, 11 increasing their positions, 10 reducing their positions, and 4 closing their positions.
New
Increased
Maintained
Reduced
Closed
more funds holding in top 10
Funds holding in top 10: →
more first-time investments, than exits
New positions opened: | Existing positions closed:
more capital invested
Capital invested by funds: $ → $
more funds holding
Funds holding: →
10% more repeat investments, than reductions
Existing positions increased: 11 | Existing positions reduced: 10
2.99% more ownership
Funds ownership: 13.45% → 16.43% (+3%)
Holders
48
Holding in Top 10
4
Calls
–
Puts
–
Top Buyers
| 1 | +$41M | |
| 2 | +$19.9M | |
| 3 | +$13.3M | |
| 4 |
DM
Deerfield Management
New York
|
+$10.5M |
| 5 |
DCM
Driehaus Capital Management
Chicago,
Illinois
|
+$8.14M |
Top Sellers
| 1 | -$11.2M | |
| 2 | -$4.16M | |
| 3 | -$3.08M | |
| 4 |
AG
Artal Group
Luxembourg
|
-$1.78M |
| 5 |
Federated Hermes
Pittsburgh,
Pennsylvania
|
-$1.58M |